维生素D检测市场－2026-2031年预测

预计维生素 D 检测市场将从 2025 年的 948,438,000 美元成长到 2031 年的 1,567,131,000 美元，复合年增长率为 8.73%。

维生素D检测市场正经历强劲的需求成长，这主要得益于人们普遍认识到维生素D在骨骼健康、免疫功能以及预防慢性疾病（包括骨质疏鬆症、1型糖尿病和某些恶性肿瘤）方面的重要作用。维生素D缺乏仍然是全球公共卫生面临的一大挑战，人们普遍认为维生素D缺乏会增加高血压、气喘加重、自体免疫疾病、失智症、忧郁症和多种癌症的风险。不断提高的健康意识以及越来越多的证据表明低25-羟基维生素D水平与不良后果相关，持续推动基层医疗、内分泌学和预防医学领域开展维生素D筛检。

骨质疏鬆症及相关脆性骨折的日益普遍，尤其是在高龄化社会中，是推动市场发展的关键因素。国际骨质疏鬆症基金会报告称，50岁及以上的女性中，每三人就有一人会经历骨质疏鬆性骨折；男性中，每五人就有一人会经历骨质疏鬆性骨折。全球每年约有890万例与骨质疏鬆症相关的骨折。老年人和身心障碍者由于户外活动受限，导致久坐的室内生活方式、极端天气以及日照减少，进一步加剧了骨质疏鬆症的发生率，从而产生了对精准诊断监测的持续需求。

政府和非政府组织所进行的宣传活动已被证明能有效将潜在的维生素D短缺转化为可衡量的检测量。强调增强免疫力和预防慢性病的系统性公共卫生宣传活动持续推动消费者和医生主导进行维生素D检测，尤其是在以往维生素D水平认知度较低的地区。

预计北美将在整个预测期内保持市场领先地位，这主要得益于50岁及以上人群骨质疏鬆症负担的加重、先进的检测基础设施以及积极的标准化倡议。美国疾病管制与预防中心（CDC）的维生素D标准化和认证计画仍然是检测可靠性的基础，确保了分析的准确性和跨平台可比性。高人均医疗保健支出和广泛的预防性筛检保险覆盖进一步巩固了该地区的市场主导地位。

由于25-羟基维生素D半衰期长、稳定性好，且与全身蕴藏量具有明确的相关性，因此其检测在临床实务中仍占据主导地位。骨化三醇（1,25-二羟基维生素D）检测在某些肾臟和副甲状腺疾病中仍具有一定的效用，但在常规检测量中所占比例仍然很小。

主要诊断试剂生产商凭藉其获得 FDA 批准和 CDC 认证的平台，保持强大的市场地位。

• 雅培公司推出 Architect 25-OH 维生素 D检测法，这是一款全自动化学冷光微粒免疫检测盒，具有高通量功能，适用于医院和实验室。
• 西门子医疗销售的「总维生素 D 检测」已获得 CDC 认证，并具有经过验证的儿童检验范围，可支援对所有年龄层进行准确解读。

近期产品创新主要集中在降低侦测门槛的去分散式检查模式。 2023年2月，Hurdle公司推出了Chronomics品牌的实验室级维生素D家用检测套组，消费者可在家中自行采集检体，并由集中式实验室进行分析。此类产品顺应了远距远端医疗和预防保健的趋势，推动了检测方式从传统的血液采集场所扩展到更广泛的领域。

整体而言，维生素D检测产业正受益于流行病学、行为学和技术等多方面因素的协同作用。维生素D缺乏症的持续流行、人口老化、室内生活方式的转变以及面向消费者的直接服务的不断扩展，共同推动了市场的持续成长。预计北美将继续在检测量和分析标准化方面主导，而25-羟基维生素D仍然是公认的黄金标准指标。公共卫生领域持续关注优化免疫功能和预防骨折，这必将使已开发经济体和新兴经济体的医疗保健系统对可靠且便捷的维生素D状态评估的需求保持在高位。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 依维生素类型分類的维生素D检测市场

• 介绍
• 维生素D2
• 维生素D3

6. 依检测方法分類的维生素D检测市场

• 介绍
• 25-羟基维生素D检测
• 1,25-二羟基维生素D检测

7. 维生素D检测市场依方法论划分

• 介绍
• 免疫检测
• 液相层析法/质谱联用（LC-MS）
• 其他的

第八章：维生素D检测市场应用

• 介绍
• 骨软化症
• 疳
• 骨质疏鬆症
• 其他的

9. 按最终用户分類的维生素D检测市场

• 介绍
• 医院和诊所
• 诊断中心
• 其他的

第十章 各地区维生素D检测市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第十一章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十二章：公司简介

• Abbott
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• BIOMERIEUX
• DiaSorin SpA
• Thermo Fisher Scientific Inc.
• Beckman Coulter, Inc.
• Tosoh Bioscience, Inc.
• Bio-Rad Laboratories, Inc

第十三章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

The vitamin D testing market, with a 8.73% CAGR, is expected to grow to USD 1567.131 million in 2031 from USD 948.438 million in 2025.

The vitamin D testing market is experiencing robust demand growth, driven by widespread recognition of vitamin D's critical role in skeletal health, immune function, and prevention of chronic conditions including osteoporosis, type 1 diabetes, and certain malignancies. Hypovitaminosis D remains a global public health challenge, with deficiency implicated in heightened risk of hypertension, asthma exacerbation, autoimmune disorders, dementia, depression, and various cancers. Increasing health consciousness and expanding evidence linking low 25-hydroxyvitamin D levels to adverse outcomes continue to propel screening uptake across primary care, endocrinology, and preventive medicine settings.

Key market catalysts include the escalating prevalence of osteoporosis and related fragility fractures, particularly in aging populations. The International Osteoporosis Foundation reports that one in three women and one in five men over age 50 will sustain an osteoporotic fracture, while approximately 8.9 million osteoporosis-related fractures occur annually worldwide. Reduced sunlight exposure secondary to sedentary indoor lifestyles, extreme weather patterns, and limited outdoor mobility among elderly and disabled individuals further compounds deficiency rates, creating sustained need for accurate diagnostic monitoring.

Awareness initiatives from governmental and non-governmental organizations are proving instrumental in converting latent deficiency into measurable testing volume. Structured public health campaigns emphasizing immune resilience and chronic disease prevention continue to drive consumer and physician-initiated testing, particularly in regions with historically low baseline knowledge of vitamin D status.

North America is poised to retain market leadership throughout the forecast period, supported by elevated osteoporosis burden among individuals aged 50 and older, advanced laboratory infrastructure, and proactive standardization efforts. The CDC Vitamin D Standardization-Certification Program remains a cornerstone for assay reliability, ensuring analytical accuracy and comparability across platforms. High per-capita healthcare expenditure and broad insurance coverage for preventive screening further solidify regional dominance.

The 25-hydroxyvitamin D assay continues to dominate clinical practice due to its long half-life, stability, and established correlation with total body stores. Calcitriol (1,25-dihydroxyvitamin D) testing retains niche utility in specific renal and parathyroid disorders but constitutes a minor share of routine volume.

Major diagnostic manufacturers maintain strong positions through FDA-cleared and CDC-certified platforms:

• Abbott offers the Architect 25-OH Vitamin D assay, a fully automated chemiluminescent microparticle immunoassay delivering high-throughput performance in hospital and reference laboratories.
• Siemens Healthineers markets the Vitamin D Total Assay, notable for CDC certification and pediatric reference interval validation, supporting accurate interpretation across age groups.

Recent product innovation has centered on decentralized testing models that lower access barriers. In February 2023, Hurdle introduced a laboratory-grade vitamin D home testing kit under its Chronomics brand, providing consumers direct-to-home sample collection with centralized laboratory analysis. Such offerings align with broader telehealth and preventive wellness trends, expanding testing beyond traditional phlebotomy settings.

Overall, the vitamin D testing sector benefits from converging epidemiological, behavioral, and technological tailwinds. Persistent deficiency prevalence, aging demographics, indoor lifestyle shifts, and expanding direct-to-consumer options collectively underpin sustained market expansion. North America will continue to lead in both testing volume and analytical standardization, while 25-hydroxyvitamin D remains the unequivocal gold-standard marker. Ongoing public health emphasis on immune optimization and fracture prevention ensures that demand for reliable, accessible vitamin D status assessment will remain elevated across developed and emerging healthcare systems alike.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Global Vitamin D Testing Market is analyzed into the following segments:

• By Vitamin Type
• Vitamin D2
• Vitamin D3
• By Test Type
• 25-Hydroxyvitamin D Testing
• 1,25-Dihydroxyvitamin D Testing
• By Method
• Immunoassay
• Liquid Chromatography/Mass Spectroscopy (LC-MS)
• Others
• By Application
• Osteomalacia
• Rickets
• Osteoporosis
• Others
• By End-User
• Hospitals & Clinics
• Diagnostics Centers
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VITAMIN D TESTING MARKET BY VITAMIN TYPE

• 5.1. Introduction
• 5.2. Vitamin D2
• 5.3. Vitamin D3

6. VITAMIN D TESTING MARKET BY TEST TYPE

• 6.1. Introduction
• 6.2. 25-Hydroxyvitamin D Testing
• 6.3. 1,25-Dihydroxyvitamin D Testing

7. VITAMIN D TESTING MARKET BY METHOD

• 7.1. Introduction
• 7.2. Immunoassay
• 7.3. Liquid Chromatography/ Mass Spectroscopy (LC-MS)
• 7.4. Others

8. VITAMIN D TESTING MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Osteomalacia
• 8.3. Rickets
• 8.4. Osteoporosis
• 8.5. Others

9. VITAMIN D TESTING MARKET BY END-USER

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Diagnostics Centers
• 9.4. Others

10. VITAMIN D TESTING MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. USA
  • 10.2.2. Canada
  • 10.2.3. Mexico
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Others
• 10.4. Europe
  • 10.4.1. Germany
  • 10.4.2. France
  • 10.4.3. United Kingdom
  • 10.4.4. Spain
  • 10.4.5. Others
• 10.5. Middle East and Africa
  • 10.5.1. Saudi Arabia
  • 10.5.2. UAE
  • 10.5.3. Israel
  • 10.5.4. Others
• 10.6. Asia Pacific
  • 10.6.1. China
  • 10.6.2. India
  • 10.6.3. Japan
  • 10.6.4. South Korea
  • 10.6.5. Indonesia
  • 10.6.6. Thailand
  • 10.6.7. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Market Share Analysis
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Competitive Dashboard

12. COMPANY PROFILES

• 12.1. Abbott
• 12.2. F. Hoffmann-La Roche Ltd
• 12.3. Siemens Healthineers AG
• 12.4. Quest Diagnostics Incorporated
• 12.5. BIOMERIEUX
• 12.6. DiaSorin S.p.A.
• 12.7. Thermo Fisher Scientific Inc.
• 12.8. Beckman Coulter, Inc.
• 12.9. Tosoh Bioscience, Inc.
• 12.10. Bio-Rad Laboratories, Inc

13. APPENDIX

• 13.1. Currency
• 13.2. Assumptions
• 13.3. Base and Forecast Years Timeline
• 13.4. Key Benefits for the Stakeholders
• 13.5. Research Methodology
• 13.6. Abbreviations